Self-Retained Amniotic Membrane Combined With Antiviral Therapy for Herpetic Epithelial Keratitis.
Self-Retained Amniotic Membrane Combined With Antiviral Therapy for Herpetic Epithelial Keratitis.
复制标题
DOI:
10.1097/ico.0000000000001316
复制
发表时间:
2017-11
期刊:
影响因子:
2.8
通讯作者:
Tseng SCG
中科院分区:
文献类型:
--
作者:
Cheng AMS;Tseng SCG
To evaluate the therapeutic benefit of self-retained cryopreserved amniotic membrane (CAM) in conjunction with oral antiviral therapy in herpetic epithelial keratitis. Retrospective review of 4 patients with primary (1 eye) and recurrent (3 eyes) unilateral herpetic epithelial keratitis treated with CAM through the placement of PROKERA® Slim (Bio-Tissue, Miami, FL) (PKS) in conjunction with oral acyclovir. Their symptoms, conjunctival inflammation, corneal staining, and visual acuity were compared before and after treatment. The herpetic epithelial keratitis presented as dendritic (3 eyes) and geographic (1 eye) epithelial lesions. Following epithelial debridement and placement of PKS for 5 ± 3.7 days, all patients reported a significant relief of symptoms, rapid corneal epithelization, and reduction of ocular surface inflammation. The visual acuity was also improved in all eyes from 0.7 ± 0.7 to 0.4 ± 0.7 logMAR (P = 0.2). They remained symptom-free during a follow-up period of 2.7 to 50.8 (20.3 ± 21.7) months. PKS in conjunction with oral acyclovir facilitates the ease of early intervention to accelerate restoration of a normal corneal epithelium in herpetic epithelial keratitis.